Loading stock data…
The Oncology Institute (TOI)
$5.60+0.21 (+3.90%)
After Hours$5.61+0.01 (+0.18%)· Last close Jun 29
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Oncology Institute, Inc. in the Healthcare sector is trading at $5.60 with a market capitalization of $520M. Wall Street consensus targets $7.75 (4 analysts), implying a +38.4% move over the next 12 months. The stock is currently near its 52-week high of $5.80, remaining 54.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +38.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $147.44M↑ | $141.96M↑ | $136.56M↑ | $119.80M↑ | $104.41M |
| Gross Profit | $23.32M↑ | $22.77M↑ | $18.92M↑ | $17.50M↑ | $17.25M |
| Operating Income | -$6.51M↑ | -$6.91M↑ | -$8.05M↑ | -$11.21M↓ | -$9.91M |
| Net Income | -$2.49M↑ | -$7.51M↑ | -$16.50M↑ | -$17.01M↑ | -$19.59M |
Peer Comparison
JNJUNHPFE
Fundamentals
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$519.91M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
267.20%
Volume
Today's trading volume
2.82M
Recent News
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?
The Oncology Institute (TOI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%
The average of price targets set by Wall Street analysts indicates a potential upside of 38.1% in The Oncology Institute (TOI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Undervalued Small Caps With Insider Buying For May 2026
Over the last 7 days, the United States market has remained flat, yet it has experienced a notable 24% rise over the past year with earnings expected to grow by 17% annually in the coming years. In this context, identifying small-cap stocks that are undervalued and show signs of insider buying can be a strategic approach for investors seeking opportunities that align with these market dynamics.
The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00
The Oncology Institute, Inc. ( NASDAQ:TOI ) defied analyst predictions to release its quarterly results, which were...
Oncology Institute Q1 Earnings Call Highlights
Oncology Institute (NASDAQ:TOI) reported a strong start to 2026, with first-quarter revenue rising 41% year over year as the company expanded value-based care arrangements and posted record specialty pharmacy performance. Chief Executive Officer Dan Virnich said the quarter was driven by “continued